ArticleJournal of cancer research and clinical oncology2015

Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.

Judith Niesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.